MD & PATIENT ACCEPTANCE OF MICROPROCESSOR DRUG DISPENSER

Award Information
Agency:
Department of Health and Human Services
Branch:
N/A
Amount:
$25,881.00
Award Year:
1989
Program:
SBIR
Phase:
Phase I
Contract:
N/A
Agency Tracking Number:
11041
Solicitation Year:
N/A
Solicitation Topic Code:
N/A
Solicitation Number:
N/A
Small Business Information
Medical Microsystems Inc
1707 Hawthorne Pl, Box 7017, Boulder, CO, 80302
Hubzone Owned:
N
Socially and Economically Disadvantaged:
N
Woman Owned:
N
Duns:
N/A
Principal Investigator
 () -
Business Contact
Phone: () -
Research Institution
N/A
Abstract
THE LONG-TERM OBJECTIVE IS TO COMPLETE DEVELOPMENT OF A MICROPROCESSOR-CONTROLLED MEDICATION DISPENSER THAT EFFECTIVELY ADDRESSES THE PROBLEM OF PATIENT COMPLIANCE. THIS TECHNOLOGY OFFERS THREE IMPORTANT FUNCTIONS FOR ADDRESSING NONCOMPLIANCE: (1) IT LIMITS PATIENT ACCESS TO MEDICATION ACCORDING TO A PRESCRIBED DOSING REGIMEN; (2) IT AUDIBLY AND VISUALLY REMINDS PATIENTS WHEN MEDICATION IS DUE OR PAST DUE; AND (3) IT MONITORS PATIENTS' DISPENSINGHABITS TO ALLOW PHYSICIANS AND PHARMACISTS TO IDENTIFY AND COUNSEL PATIENTS WITH POOR COMPLIANCE HABITS. PHASE I WILL TEST PRELIMINARY ACCEPTANCE OF THIS TECHNOLOGY BY INTERNAL MEDICINE PATIENTS AND THEIR PHYSICIANS. PHASE II WILL TEST PATIENT AND PHYSICIAN ACCEPTANCE AND ITS UTILITY IN A CLINICAL SETTING FOLLOWING MODIFICATIONS BASED ON RESULTS OF THE PHASE I STUDY. PHASE II WILL ENCOMPASS ADDITIONAL CLINICAL SITES AND LARGER NUMBERS OF PATIENTS. SPECIFIC APPLICATIONS FOR MICROPROCESSOR-CONTROLLED MEDICATION DISPENSING (E.G., ELDERLY PATIENTS TAKING MULTIPLE MEDICATIONS, ASTHMATICS, AND HYPERTENSIVES) WILL ALSO BE ADDRESSED.

* information listed above is at the time of submission.

Agency Micro-sites

US Flag An Official Website of the United States Government